He has made key contributions in various fields of cancer immunotherapy, covering the discovery of tumor-associated antigens, development of novel monoclonal antibodies for the treatment of solid cancers and various classes of RNA-based immunotherapies.
Ugur Sahin is a Professor at the University Medical Center of Johannes Gutenberg University Mainz, co-founder and CEO of BioNTech (2008) and co-founder and shareholder of TRON (2010). He was TRON´s scientific managing director from 2010 until September 2019. He supports the research and development at TRON as a close scientific advisor and supervisor for PhD students.
Prof. Sahin also served as the head of the Scientific Advisory Board of Ganymed Pharmaceuticals AG from 2008 until the company was acquired by Astellas Pharma Inc., or Astellas, in 2016.
Prof. Sahin is also the co-founder of Ci3, the German Cluster Initiative of Individualized ImmunIntervention (Ci3), a non-profit organization.
Ugur Sahin earned an M.D. in 1990 from the University of Cologne. He is married to Dr. Özlem Türeci.
Catch up on the latest and greatest in the world of International Turks
Citizens of Turkuaz Republic are globetrotters, praised for their ability to adjust to new circumstance, which they owe to their nomadic Turkic past.
With the internet age, many post their experience on Youtube, and we take great joy in enlisting them to help them connect, share and inspire!
Please visit our Community Pages and send us your video on your experience in the International Turkish Community. We look forward to publishing your experience!